This webinar has been initiated and commissioned by Intercept Pharma UK and Ireland Ltd and organised in partnership with GuidelinesIntercept Pharma UK and Ireland Ltd has reviewed the scope of the webinar, commissioned the speakers, and approved all materials related to the webinar. The speakers have been paid an honorarium. The views and opinions of the speakers are not necessarily those of Intercept Pharma UK and Ireland Ltd or of Guidelines, its publisher, advisers, and advertisers.

Webinar banner 3x2

Click here to register for free

Thursday 15 October 2020, 12.30–13.30

This 1-hour Guidelines webinar will:

  • educate GPs on the recognition of patients presenting with advanced fibrosis due to NASH in primary care
  • discuss best practice in managing patients with advanced fibrosis due to NASH in primary care
  • delineate appropriate pathways for referral of patients to secondary care
  • discuss the management of patients with advanced fibrosis due to NASH in secondary care.

Register and submit your questions to the speakers:

Dr Helen Jarvis

GP, West Road Medical Centre, Newcastle
NIHR Doctoral Research Fellow, Newcastle University
RCGP national liver disease clinical champion 2017–2019
Lancet Liver Commissioning
British Liver Trust clinical advisory group

Dr Jeremy Cobbold cropped

Dr Jeremy Cobbold

Consultant Hepatologist and Clinical Lead for Hepatology, 
Oxford University Hospitals NHS Foundation Trust
Honorary Senior Clinical Lecturer, University of Oxford



Click here to register for free

NASH=non-alcoholic steatohepatitis.

UK-NAS-MED-00108
Date of preparation: July 2020